High-mobility group box 1 and cancer
- 28 February 2010
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1799 (1-2), 131-140
- https://doi.org/10.1016/j.bbagrm.2009.11.014
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapyImmunological Reviews, 2007
- High Mobility Group Protein B1 Is an Activator of Apoptotic Response to Antimetabolite DrugsMolecular Pharmacology, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Damage associated molecular pattern moleculesClinical Immunology, 2007
- Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1Journal of Leukocyte Biology, 2006
- Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculatureBlood, 2006
- Role of HMGB1 in apoptosis-mediated sepsis lethalityThe Journal of Experimental Medicine, 2006
- Inflammation and necrosis promote tumour growthNature Reviews Immunology, 2004
- Association of Chromatin Proteins High Mobility Group Box (HMGB) 1 and HMGB2 with Mitotic ChromosomesMolecular Biology of the Cell, 2003
- The Hallmarks of CancerCell, 2000